Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011949

President sold 85,000 shares at an average $33.57 ($2,853,294)

  • President acquired 85,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2020-02-20 Option exercise +80,000 $0.84 $67,200 80,000 D
RUBINSTEIN JULIE President 2020-02-20 Sale −67,800 $33.49 $2,270,622 12,200 D
RUBINSTEIN JULIE President 2020-02-20 Sale −12,200 $34.01 $414,922 0 D
RUBINSTEIN JULIE President 2020-02-21 Option exercise +5,000 $0.84 $4,200 5,000 D
RUBINSTEIN JULIE President 2020-02-21 Sale −5,000 $33.55 $167,750 0 D
Derivatives
RUBINSTEIN JULIE President 2020-02-20 Option exercise · Stock Option (Right to Buy) −80,000 225,000 D
RUBINSTEIN JULIE President 2020-02-21 Option exercise · Stock Option (Right to Buy) −5,000 220,000 D
Open-market sales · 85,000 sh · avg $33.57 · $2,853,294
Loading xslF345X03/doc4.xml…